Malignant papillary lesions of the endometrium

Gregory P. Sutton, Lessa Brill, Frederick Stehman, Clarence E. Ehrlich, Helen Michael

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

In a review of 440 patients treated for endometrial adenocarcinoma at this center since 1974, 21 patients with tumors of papillary histology were identified. Eleven (2.5%) lesions contained histologic changes characteristic of uterine papillary serous carcinoma: complex papillary architecture, high nuclear/cytoplasmic ratio, and irregular epithelial tufting. Ten lesions (2.3%) containing areas of papillary morphology but lacking the criteria for the diagnosis of papillary serous tumors were termed papillary endometrioid adenocarcinoma. Patient age, stage, and the presence of obesity, hypertension, and diabetes were similar in both groups and reflected those characteristics well established for endometrial adenocarcinoma in general. Fewer papillary serous tumors (16.7%) and papillary endometrioid tumors (33.3%) contained progesterone receptors than did other adenocarcinomas (52.3%). In clinical stage I, surgical findings indicating a more advanced stage were present in 40% of patients with papillary serous tumors compared to 10% in papillary endometrioid tumors and 12.5% in nonpapillary adenocarcinomas (P = 0.03, Fisher's exact test). Recurrences were observed in 50% of patients with papillary serous lesions compared to 42.9% in papillary endometrioid lesions and 24.3% in other adenocarcinomas. Survival for clinical stage I papillary serous tumors was worse than that for nonpapillary grade 3 controls (P = 0.042) and survival for papillary endometrioid lesions was not different from that of the same controls. These findings support those of J. L. Chen, D. C. Trost, and E. J. Wilkinson (Int. J. Gynecol. Pathol. 4, 279-288 (1985)) that papillary serous and papillary endometrioid adenocarcinomas represent two distinct subtypes of papillary endometrial neoplasia.

Original languageEnglish
Pages (from-to)294-304
Number of pages11
JournalGynecologic Oncology
Volume27
Issue number3
DOIs
StatePublished - 1987

Fingerprint

Endometrium
Adenocarcinoma
Neoplasms
Papillary Adenocarcinoma
Endometrioid Carcinoma
Survival
Papillary Carcinoma
Progesterone Receptors
Histology
Obesity
Hypertension
Recurrence

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Sutton, G. P., Brill, L., Stehman, F., Ehrlich, C. E., & Michael, H. (1987). Malignant papillary lesions of the endometrium. Gynecologic Oncology, 27(3), 294-304. https://doi.org/10.1016/0090-8258(87)90249-6

Malignant papillary lesions of the endometrium. / Sutton, Gregory P.; Brill, Lessa; Stehman, Frederick; Ehrlich, Clarence E.; Michael, Helen.

In: Gynecologic Oncology, Vol. 27, No. 3, 1987, p. 294-304.

Research output: Contribution to journalArticle

Sutton, GP, Brill, L, Stehman, F, Ehrlich, CE & Michael, H 1987, 'Malignant papillary lesions of the endometrium', Gynecologic Oncology, vol. 27, no. 3, pp. 294-304. https://doi.org/10.1016/0090-8258(87)90249-6
Sutton, Gregory P. ; Brill, Lessa ; Stehman, Frederick ; Ehrlich, Clarence E. ; Michael, Helen. / Malignant papillary lesions of the endometrium. In: Gynecologic Oncology. 1987 ; Vol. 27, No. 3. pp. 294-304.
@article{3bec988df0044a94b4ad9a79d6ddca6f,
title = "Malignant papillary lesions of the endometrium",
abstract = "In a review of 440 patients treated for endometrial adenocarcinoma at this center since 1974, 21 patients with tumors of papillary histology were identified. Eleven (2.5{\%}) lesions contained histologic changes characteristic of uterine papillary serous carcinoma: complex papillary architecture, high nuclear/cytoplasmic ratio, and irregular epithelial tufting. Ten lesions (2.3{\%}) containing areas of papillary morphology but lacking the criteria for the diagnosis of papillary serous tumors were termed papillary endometrioid adenocarcinoma. Patient age, stage, and the presence of obesity, hypertension, and diabetes were similar in both groups and reflected those characteristics well established for endometrial adenocarcinoma in general. Fewer papillary serous tumors (16.7{\%}) and papillary endometrioid tumors (33.3{\%}) contained progesterone receptors than did other adenocarcinomas (52.3{\%}). In clinical stage I, surgical findings indicating a more advanced stage were present in 40{\%} of patients with papillary serous tumors compared to 10{\%} in papillary endometrioid tumors and 12.5{\%} in nonpapillary adenocarcinomas (P = 0.03, Fisher's exact test). Recurrences were observed in 50{\%} of patients with papillary serous lesions compared to 42.9{\%} in papillary endometrioid lesions and 24.3{\%} in other adenocarcinomas. Survival for clinical stage I papillary serous tumors was worse than that for nonpapillary grade 3 controls (P = 0.042) and survival for papillary endometrioid lesions was not different from that of the same controls. These findings support those of J. L. Chen, D. C. Trost, and E. J. Wilkinson (Int. J. Gynecol. Pathol. 4, 279-288 (1985)) that papillary serous and papillary endometrioid adenocarcinomas represent two distinct subtypes of papillary endometrial neoplasia.",
author = "Sutton, {Gregory P.} and Lessa Brill and Frederick Stehman and Ehrlich, {Clarence E.} and Helen Michael",
year = "1987",
doi = "10.1016/0090-8258(87)90249-6",
language = "English",
volume = "27",
pages = "294--304",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Malignant papillary lesions of the endometrium

AU - Sutton, Gregory P.

AU - Brill, Lessa

AU - Stehman, Frederick

AU - Ehrlich, Clarence E.

AU - Michael, Helen

PY - 1987

Y1 - 1987

N2 - In a review of 440 patients treated for endometrial adenocarcinoma at this center since 1974, 21 patients with tumors of papillary histology were identified. Eleven (2.5%) lesions contained histologic changes characteristic of uterine papillary serous carcinoma: complex papillary architecture, high nuclear/cytoplasmic ratio, and irregular epithelial tufting. Ten lesions (2.3%) containing areas of papillary morphology but lacking the criteria for the diagnosis of papillary serous tumors were termed papillary endometrioid adenocarcinoma. Patient age, stage, and the presence of obesity, hypertension, and diabetes were similar in both groups and reflected those characteristics well established for endometrial adenocarcinoma in general. Fewer papillary serous tumors (16.7%) and papillary endometrioid tumors (33.3%) contained progesterone receptors than did other adenocarcinomas (52.3%). In clinical stage I, surgical findings indicating a more advanced stage were present in 40% of patients with papillary serous tumors compared to 10% in papillary endometrioid tumors and 12.5% in nonpapillary adenocarcinomas (P = 0.03, Fisher's exact test). Recurrences were observed in 50% of patients with papillary serous lesions compared to 42.9% in papillary endometrioid lesions and 24.3% in other adenocarcinomas. Survival for clinical stage I papillary serous tumors was worse than that for nonpapillary grade 3 controls (P = 0.042) and survival for papillary endometrioid lesions was not different from that of the same controls. These findings support those of J. L. Chen, D. C. Trost, and E. J. Wilkinson (Int. J. Gynecol. Pathol. 4, 279-288 (1985)) that papillary serous and papillary endometrioid adenocarcinomas represent two distinct subtypes of papillary endometrial neoplasia.

AB - In a review of 440 patients treated for endometrial adenocarcinoma at this center since 1974, 21 patients with tumors of papillary histology were identified. Eleven (2.5%) lesions contained histologic changes characteristic of uterine papillary serous carcinoma: complex papillary architecture, high nuclear/cytoplasmic ratio, and irregular epithelial tufting. Ten lesions (2.3%) containing areas of papillary morphology but lacking the criteria for the diagnosis of papillary serous tumors were termed papillary endometrioid adenocarcinoma. Patient age, stage, and the presence of obesity, hypertension, and diabetes were similar in both groups and reflected those characteristics well established for endometrial adenocarcinoma in general. Fewer papillary serous tumors (16.7%) and papillary endometrioid tumors (33.3%) contained progesterone receptors than did other adenocarcinomas (52.3%). In clinical stage I, surgical findings indicating a more advanced stage were present in 40% of patients with papillary serous tumors compared to 10% in papillary endometrioid tumors and 12.5% in nonpapillary adenocarcinomas (P = 0.03, Fisher's exact test). Recurrences were observed in 50% of patients with papillary serous lesions compared to 42.9% in papillary endometrioid lesions and 24.3% in other adenocarcinomas. Survival for clinical stage I papillary serous tumors was worse than that for nonpapillary grade 3 controls (P = 0.042) and survival for papillary endometrioid lesions was not different from that of the same controls. These findings support those of J. L. Chen, D. C. Trost, and E. J. Wilkinson (Int. J. Gynecol. Pathol. 4, 279-288 (1985)) that papillary serous and papillary endometrioid adenocarcinomas represent two distinct subtypes of papillary endometrial neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=0023630979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023630979&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(87)90249-6

DO - 10.1016/0090-8258(87)90249-6

M3 - Article

C2 - 3623228

AN - SCOPUS:0023630979

VL - 27

SP - 294

EP - 304

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -